Analysis of Structure Indicators Influencing 3-h and 6-h Compliance with the Surviving Sepsis Campaign Guidelines in China: a Systematic Review
Overview
Authors
Affiliations
Background: Compliance with the surviving sepsis campaign (SSC) guidelines (C) is a key factor affecting the effects of sepsis treatment. We designed this study to investigate the relationships of the structure indicators of ICU on 3 and 6-h C in China.
Methods: A total of 1854 hospitals were enrolled in a survey, led by the China National Critical Care Quality Control Center (China-NCCQC) from January 1, 2018, through December 31, 2018. We investigated the 1854 hospitals' 3 and 6-h C, including compliance with each specific measure of the 3-h and 6-h SSC bundles. We also investigated the actual level of the structure indicators of ICU, released by China-NCCQC in 2015.The outcomes were in adherence with the SSC guidelines (2016). Monitoring indicators included 3 and 6-h C.
Results: In the subgroup, the rate of broad-spectrum antibiotic therapy was the highest, and the rate of CVP and ScvO2 measurement was the lowest among the items of 3 and 6-h C. Structure indicators related to 3 and 6-h C include the predicted mortality rate and the standardized mortality ratio (SMR). The relationships between 3 and 6-h C and the proportion of ICU in total inpatient bed occupancy, the proportion of acute physiology and chronic health evaluation (APACHE) II score ≥ 15 in all ICU patients were uncertain. There was no relationship of 3 and 6-h C with the proportion of ICU patients among total inpatients.
Conclusions: Structure indicators influencing 3 and 6-h C in China are the predicted mortality rate and the standardized mortality rate.
Cheng W, Chen J, Ma X, Sun J, Gao S, Wang Y Front Med. 2023; 18(2):315-326.
PMID: 37991709 DOI: 10.1007/s11684-023-1014-x.
Carbapenem is not always the best choice in the treatment of septic shock.
Wang L, Ma X, Chen Y, Gao S, He H, Su L Eur J Med Res. 2023; 28(1):372.
PMID: 37749658 PMC: 10518951. DOI: 10.1186/s40001-023-01341-x.
Wang L, Ma X, He H, Su L, Guo Y, Shan G Sci Rep. 2023; 13(1):3373.
PMID: 36849534 PMC: 9971201. DOI: 10.1038/s41598-023-30551-w.